Advertisement

Histiocytic Diseases of the Lung

  • Carol Farver
  • Tracey L. Bonfield
Part of the Molecular Pathology Library book series (MPLB, volume 1)

Abstract

Histiocytic lesions of the lung are a group of diseases that arise out of defects in the lung’s macrophage population. Although histiocytes play a major role in many diseases of the lung, including granulomatous diseases (mycobacterial and fungal infections, sarcoidosis)1 and other interstitial lung disease,2 we discuss only those lesions with the primary defect in the lung histiocyte or those systemic diseases with notable lung involvement. These include pulmonary Langerhans cell histiocytosis, Erdheim-Chester disease, Niemann-Pick disease, Gaucher’s disease, and Hermansky-Pudlak syndrome.

Keywords

Interstitial Lung Disease Lamellar Body Gauche Cell Pulmonary Alveolar Proteinosis Pudlak Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Perez RL, Rivera-Marrero CA, Roman J. Pulmonary granulomatous inflammation: from sarcoidosis to tuberculosis. Semin Respir Infect 2003;18(1):23–32.CrossRefPubMedGoogle Scholar
  2. 2.
    Popper HH. Epithelioid cell granulomatosis of the lung: new insights and concepts. Sarcoidosis Vasc Diffuse Lung Dis 1999;16(1):32–46.PubMedGoogle Scholar
  3. 3.
    Favara BE, Feller AC, Pauli M, et al. Contemporary classification of histiocytic disorders. The WHO Committee on Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society. Med Pediatr Oncol 1997;29(3):157–166.CrossRefPubMedGoogle Scholar
  4. 4.
    Tazi A. Cells of the dendritic cell lineage in human lung carcinomas and pulmonary histiocytosis X. In Lipscomb M, Russell S, eds. Lung Macrophages and Dendritic Cells in Health and Disease. New York: Marcel Dekker; 1997:725–757.Google Scholar
  5. 5.
    Vassallo R, Limper AH. Pulmonary Langerhans’ cell histiocytosis. Semin Respir Crit Care Med 2002;23(2):93–101.CrossRefPubMedGoogle Scholar
  6. 6.
    Flint A, Lloyd RV, Colby TV, Wilson BW. Pulmonary histiocytosis X. Immunoperoxidase staining for HLA-DR antigen and S100 protein. Arch Pathol Lab Med 1986;110(10):930–933.PubMedGoogle Scholar
  7. 7.
    Tazi A, Bonay M, Grandsaigne M, et al. Surface phenotype of Langerhans cells and lymphocytes in granulomatous lesions from patients with pulmonary histiocytosis X. Am Rev Respir Dis 1993;147(6 Pt 1):1531–1536.PubMedGoogle Scholar
  8. 8.
    Vermaelen K, Pauwels R. Pulmonary dendritic cells. Am J Respir Crit Care Med 2005;172(5):530–551.CrossRefPubMedGoogle Scholar
  9. 9.
    Sundar KM, Gosselin MV, Chung HL, Cahill BC. Pulmonary Langerhans cell histiocytosis: emerging concepts in pathobiology, radiology, and clinical evolution of disease. Chest 2003;123(5):1673–1683.CrossRefPubMedGoogle Scholar
  10. 10.
    Annels NE, Da Costa CE, Prins FA, et al. Aberrant chemokine receptor expression and chemokine production by Langerhans cells underlies the pathogenesis of Langerhans cell histiocytosis. J Exp Med 2003;197(10):1385–1390.CrossRefPubMedGoogle Scholar
  11. 11.
    Wang J, Snider DP, Hewlett BR, et al. Transgenic expression of granulocyte-macrophage colony-stimulating factor induces the differentiation and activation of a novel dendritic cell population in the lung. Blood 2000;95(7):2337–2345.PubMedGoogle Scholar
  12. 12.
    de Graaf JH, Tamminga RY, Dam-Meiring A, et al. The presence of cytokines in Langerhans’ cell histiocytosis. J Pathol 1996;180(4):400–406.CrossRefPubMedGoogle Scholar
  13. 13.
    Tazi A, Moreau J, Bergeron A, et al. Evidence that Langerhans cells in adult pulmonary Langerhans cell histiocytosis are mature dendritic cells: importance of the cytokine microenvironment. J Immunol 1999;163(6):3511–3515.PubMedGoogle Scholar
  14. 14.
    Yousem SA, Colby TV, Chen YY, et al. Pulmonary Langerhans’ cell histiocytosis: molecular analysis of clonality. Am J Surg Pathol 2001;25(5):630–636.CrossRefPubMedGoogle Scholar
  15. 15.
    Dacic S, Trusky C, Bakker A, et al. Genotypic analysis of pulmonary Langerhans cell histiocytosis. Hum Pathol 2003;34(12):1345–1349.CrossRefPubMedGoogle Scholar
  16. 16.
    Casolaro MA, Bernaudin JF, Saltini C, et al. Accumulation of Langerhans’ cells on the epithelial surface of the lower respiratory tract in normal subjects in association with cigarette smoking. Am Rev Respir Dis 1988;137(2):406–411.PubMedGoogle Scholar
  17. 17.
    Willman CL, McClain KL. An update on clonality, cytokines, and viral etiology in Langerhans cell histiocytosis. Hematol Oncol Clin North Am 1998;12(2):407–416.CrossRefPubMedGoogle Scholar
  18. 18.
    Tazi A, Soler P, Hance AJ. Adult pulmonary Langerhans’ cell histiocytosis. Thorax 2000;55(5):405–416.CrossRefPubMedGoogle Scholar
  19. 19.
    Egan AJ, Boardman LA, Tazelaar HD, et al. Erdheim-Chester disease: clinical, radiologic, and histopathologic findings in five patients with interstitial lung disease. Am J Surg Pathol 1999;23(1):17–26.CrossRefPubMedGoogle Scholar
  20. 20.
    Veyssier-Belot C, Cacoub P, Caparros-Lefebvre D, et al. Erdheim-Chester disease. Clinical and radiologic characteristics of 59 cases. Medicine (Baltimore) 1996;75(3):157–169.CrossRefGoogle Scholar
  21. 21.
    Kambouchner M, Colby TV, Domenge C, et al. Erdheim-Chester disease with prominent pulmonary involvement associated with eosinophilic granuloma of mandibular bone. Histopathology 1997;30(4):353–358.CrossRefPubMedGoogle Scholar
  22. 22.
    Madroszyk A, Wallaert B, Remy M, et al. [Diffuse interstitial pneumonia revealing Erdheim-Chester’s disease.] Rev Mal Respir 1994;11(3):304–307.PubMedGoogle Scholar
  23. 23.
    Murray D, Marshall M, England E, et al. Erdheim-Chester disease. Clin Radiol 2001;56(6):481–484.CrossRefPubMedGoogle Scholar
  24. 24.
    Shamburek RD, Brewer HB Jr, Gochuico BR. Erdheim-Chester disease: a rare multisystem histiocytic disorder associated with interstitial lung disease. Am J Med Sci 2001;321(1):66–75.CrossRefPubMedGoogle Scholar
  25. 25.
    Rao RN, Chang CC, Uysal N, et al. Fulminant multisystem non-Langerhans cell histiocytic proliferation with hemophagocytosis: a variant form of Erdheim-Chester disease. Arch Pathol Lab Med 2005;129(2):e39–e43.PubMedGoogle Scholar
  26. 26.
    Rush WL, Andriko JA, Galateau-Salle F, et al. Pulmonary pathology of Erdheim-Chester disease. Mod Pathol 2000;13(7):747–754.CrossRefPubMedGoogle Scholar
  27. 27.
    Devouassoux G, Lantuejoul S, Chatelain P, et al. Erdheim-Chester disease: a primary macrophage cell disorder. Am J Respir Crit Care Med 1998;157(2):650–653.PubMedGoogle Scholar
  28. 28.
    Myra C, Sloper L, Tighe PJ, et al. Treatment of Erdheim-Chester disease with cladribine: a rational approach. Br J Ophthalmol 2004;88(6):844–847.CrossRefPubMedGoogle Scholar
  29. 29.
    Wittenberg KH, Swensen SJ, Myers JL. Pulmonary involvement with Erdheim-Chester disease: radiographic and CT findings. AJR Am J Roentgenol 2000;174(5):1327–1331.PubMedGoogle Scholar
  30. 30.
    Chetritt J, Paradis V, Dargere D, et al. Chester-Erdheim disease: a neoplastic disorder. Hum Pathol 1999;30(9):1093–1096.CrossRefPubMedGoogle Scholar
  31. 31.
    Germain DP. Gaucher’s disease: a paradigm for interventional genetics. Clin Genet 2004;65(2):77–86.CrossRefPubMedGoogle Scholar
  32. 32.
    Amir G, Ron N. Pulmonary pathology in Gaucher’s disease. Hum Pathol 1999;30(6):666–670.CrossRefPubMedGoogle Scholar
  33. 33.
    Goitein O, Elstein D, Abrahamov A, et al. Lung involvement and enzyme replacement therapy in Gaucher’s disease. Q J Med 2001;94(8):407–415.Google Scholar
  34. 34.
    Zhao H, Grabowski GA. Gaucher disease: perspectives on a prototype lysosomal disease. Cell Mol Life Sci 2002;59(4):694–707.CrossRefPubMedGoogle Scholar
  35. 35.
    Lichtenstein M, Zimran A, Horowitz M. Cytokine mRNA in Gaucher disease. Blood Cells Mol Dis 1997;23(3):395–401.CrossRefPubMedGoogle Scholar
  36. 36.
    Vellodi A. Lysosomal storage disorders. Br J Haematol 2005;128(4):413–431.CrossRefPubMedGoogle Scholar
  37. 37.
    Mendelson DS, Wasserstein MP, Desnick RJ, et al. Type B Niemann-Pick disease: findings at chest radiography, thin-section CT, and pulmonary function testing. Radiology 2006;238(1):339–345.CrossRefPubMedGoogle Scholar
  38. 38.
    Nicholson AG, Wells AU, Hooper J, et al. Successful treatment of endogenous lipoid pneumonia due to Niemann-Pick type B disease with whole-lung lavage. Am J Respir Crit Care Med 2002;165(1):128–131.PubMedGoogle Scholar
  39. 39.
    Minai OA, Sullivan EJ, Stoller JK. Pulmonary involvement in Niemann-Pick disease: case report and literature review. Respir Med 2000;94(12):1241–1251.CrossRefPubMedGoogle Scholar
  40. 40.
    Nicholson AG, Florio R, Hansell DM, et al. Pulmonary involvement by Niemann-Pick disease. A report of six cases. Histopathology 2006;48(5):596–603.CrossRefPubMedGoogle Scholar
  41. 41.
    Elleder M, Houstkova H, Zeman J, et al. Pulmonary storage with emphysema as a sign of Niemann-Pick type C2 disease (second complementation group). Report of a case. Virchows Arch 2001;439(2):206–211.CrossRefPubMedGoogle Scholar
  42. 42.
    Dhami R, He X, Gordon RE, Schuchman EH. Analysis of the lung pathology and alveolar macrophage function in the acid sphingomyelinase—deficient mouse model of Niemann-Pick disease. Lab Invest 2001;81(7):987–999.PubMedGoogle Scholar
  43. 43.
    Ikegami M, Dhami R, Schuchman EH. Alveolar lipoproteinosis in an acid sphingomyelinase-deficient mouse model of Niemann-Pick disease. Am J Physiol Lung Cell Mol Physiol 2003;284(3):L518–L525.PubMedGoogle Scholar
  44. 44.
    Kobashi Y, Yoshida K, Miyashita N, et al. Hermansky-Pudlak syndrome with interstitial pneumonia without mutation of HSP1 gene. Intern Med 2005;44(6):616–621.CrossRefPubMedGoogle Scholar
  45. 45.
    Lederer DJ, Kawut SM, Sonett JR, et al. Successful bilateral lung transplantation for pulmonary fibrosis associated with the Hermansky-Pudlak syndrome. J Heart Lung Transplant 2005;24(10):1697–1699.CrossRefPubMedGoogle Scholar
  46. 46.
    Tang X, Yamanaka S, Miyagi Y, et al. Lung pathology of pale ear mouse (model of Hermansky-Pudlak syndrome 1) and beige mouse (model of Chediak-Higashi syndrome): severity of giant lamellar body degeneration of type II pneumocytes correlates with interstitial inflammation. Pathol Int 2005;55(3):137–143.CrossRefPubMedGoogle Scholar
  47. 47.
    Witkop CJ Jr, White JG, Gerritsen SM, et al. Hermansky-Pudlak syndrome (HPS): a proposed block in glutathione peroxidase. Oral Surg Oral Med Oral Pathol 1973;35(6):790–806.CrossRefPubMedGoogle Scholar
  48. 48.
    Li W, Rusiniak ME, Chintala S, et al. Murine Hermansky-Pudlak syndrome genes: regulators of lysosome-related organelles. Bioessays 2004;26(6):616–628.CrossRefPubMedGoogle Scholar
  49. 49.
    Wei ML. Hermansky-Pudlak syndrome: a disease of protein trafficking and organelle function. Pigment Cell Res 2006;19(1):19–42.CrossRefPubMedGoogle Scholar
  50. 50.
    Nakatani Y, Nakamura N, Sano J, et al. Interstitial pneumonia in Hermansky-Pudlak syndrome: significance of florid foamy swelling/degeneration (giant lamellar body degeneration) of type-2 pneumocytes. Virchows Arch 2000;437(3):304–313.CrossRefPubMedGoogle Scholar
  51. 51.
    Brantly M, Avila NA, Shotelersuk V, et al. Pulmonary function and high-resolution CT findings in patients with an inherited form of pulmonary fibrosis, Hermansky-Pudlak syndrome, due to mutations in HPS-1. Chest 2000;117(1):129–136.CrossRefPubMedGoogle Scholar
  52. 52.
    Oh J, Bailin T, Fukai K, et al. Positional cloning of a gene for Hermansky-Pudlak syndrome, a disorder of cytoplasmic organelles. Nat Genet 1996;14(3):300–306.CrossRefPubMedGoogle Scholar
  53. 53.
    Lyerla TA, Rusiniak ME, Borchers M, et al. Aberrant lung structure, composition, and function in a murine model of Hermansky-Pudlak syndrome. Am J Physiol Lung Cell Mol Physiol 2003;285(3):L643–L653.PubMedGoogle Scholar
  54. 54.
    Gahl WA, Brantly M, Kaiser-Kupfer MI, et al. Genetic defects and clinical characteristics of patients with a form of oculocutaneous albinism (Hermansky-Pudlak syndrome). N Engl J Med 1998;338(18):1258–1264.CrossRefPubMedGoogle Scholar
  55. 55.
    Pierson DM, Ionescu D, Qing G, et al. Pulmonary fibrosis in Hermansky-Pudlak syndrome. A case report and review. Respiration 2006;73(3):382–395.CrossRefPubMedGoogle Scholar
  56. 56.
    Anderson PD, Huizing M, Claassen DA, et al. Hermansky-Pudlak syndrome type 4 (HPS-4): clinical and molecular characteristics. Hum Genet 2003;113(1):10–17.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC. 2008

Authors and Affiliations

  • Carol Farver
    • 1
  • Tracey L. Bonfield
    • 2
  1. 1.Pulmonary Pathology, Department of Anatomic PathologyCleveland Clinic FoundationClevelandUSA
  2. 2.Department of Pediatric PulmonaryCase Western Reserve University School of MedicineCleveland

Personalised recommendations